Remedent, Inc. (REMI)

Remedent Cash Flow Statement

Financials in millions EUR. Fiscal year is April - March.

Fiscal Year	FY 2019
Period Ending	Mar 31, 2019
Net Income	1.9
Depreciation & Amortization	0.09
Loss (Gain) on Equity Investments	-2.54
Provision & Write-off of Bad Debts	-0.03
Other Operating Activities	-0.06
Change in Accounts Receivable	0.82
Change in Inventory	0.01
Change in Accounts Payable	0.31
Change in Unearned Revenue	-0.02
Change in Other Net Operating Assets	0.02
Operating Cash Flow	0.51
Operating Cash Flow Growth	2965.32%
Foreign Exchange Rate Adjustments	-0.53
Net Cash Flow	-0.02
Free Cash Flow	0.51
Free Cash Flow Growth	3829.67%
Free Cash Flow Margin	35.39%
Free Cash Flow Per Share	0.03
Cash Interest Paid	0.01
Levered Free Cash Flow	0.88
Unlevered Free Cash Flow	0.89
Change in Working Capital	1.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.